Andreas Peschel

@andreaspeschel.bsky.social

Professor of Microbiology at the University of Tübingen, studying Staphylococcus biology and pathogenicity

Excited that #DZIF is part of the #REPhRAME consortium: Together with our partners from across Europe, we are advancing innovative approaches to tackle antimicrobial resistance and translate research into better patient care. We look forward to working together! 🚀 t1p.de/6mcot #AMR #HorizonEurope

Viruses against bacteria: EU funds phage therapy with €15 million | German Center for Infection Research

Bacteria are becoming increasingly resistant to antibiotics. One alternative is treatment with viruses that exclusively infect bacteria, known as phages.

t1p.de

Goethe-Universität Frankfurt@goetheuni.bsky.social · last mo.

🦠🧪 #Viren gegen Bakterien statt immer mehr #Antibiotika? An der #Unimedizin Frankfurt erhält das Forschungsprojekt #REPhRAME 15 Mio. € aus Horizon Europe. Ziel: neue Therapien gegen wiederkehrende Harnwegsinfektionen. 🔗 www.uni-frankfurt.de/de/newsroom/...

Grafik zur Phagentherapie mit einer Illustration eines Bakteriophagen, der an einer Bakterienzelle andockt. Im Hintergrund sind mehrere stäbchenförmige Bakterien zu sehen. Der Text lautet: „Mit Viren gegen Bakterien: 15 Millionen für Phagentherapie“. Darunter wird erläutert, dass die Universitätsmedizin Frankfurt unter der Leitung von Prof. Dr. Maria J.G.T. Vehreschild 15 Millionen Euro aus Horizon Europe für das Forschungsprojekt REPhRAME erhält. Ziel ist die Entwicklung einer neuen Phagentherapie gegen wiederkehrende Harnwegsinfektionen. Unten links sind die Logos der Goethe-Universität und der Europäischen Union abgebildet. Am rechten Bildrand steht der Bildnachweis „© peterschreiber.media/Shutterstock.com“.

Thank you @michiwagner4.bsky.social for your seminar talk. Looking forward to close ties between @microbesplanet.bsky.social and @cmfi.bsky.social

Michael Wagner@michiwagner4.bsky.social · 3mo ago

Many thanks @andreaspeschel.bsky.social for inviting me to give a talk on “Chemical imaging-based insights into the human gut microbiome- drug interaction network” at the CMFI - Cluster of Excellence (CoE) at the Univ. of Tübingen. @microbesplanet.bsky.social & @cemess.bsky.social #MicroSky 🧪

A teichoic acid-like wall modification associated with immune suppression is socially regulated in Streptococcus pyogenes | mBio journals.asm.org/doi/10.1128/...

A teichoic acid-like wall modification associated with immune suppression is socially regulated in Streptococcus pyogenes | mBio

Streptococcus pyogenes is a major human pathogen, responsible for diverse clinical manifestations of both superficial and invasive infections, and can lead to post-infection sequelae like rheumatic heart disease, whose prevalence on a global scale rivals that of the most serious pathogens. Invasive S. pyogenes infections are currently on the rise worldwide, notably correlating with increasing pediatric cases of scarlet fever and enhancing the concern for long-term complications. There is much that remains unknown about S. pyogenes virulence and pathogenicity, and studies focused on understanding basic systems regulating virulence factors could lead to better therapeutics and translational research. We show here one such example, where a bacterial communication system regulating a virulence mechanism relevant to in vivo infection confers the ability to alter the host’s innate immune response. We find that modifications to the cell wall arise when this virulence system is activated, which has a direct role in host-pathogen interactions. Further research into this system could provide a mechanism for disruption and serve to treat S. pyogenes infection.

journals.asm.org

"Research is often described as ‘basic’, but there is nothing basic about it. The links between discovery-based research and downstream applications aren’t always clear at the outset. Although a translational output may require years to achieve" www.nature.com/articles/s41...

Advancing microbiology through foundational science - Nature Microbiology

Microorganisms have tremendous potential to impact humanity, but such revelations are only possible in the light of foundational, discovery-based microbiology research.

nature.com

Researchers, clinicians, and trainees from around the world will come together to share the latest discoveries in: • Staphylococcus biology • Pathogenesis and host interactions • Epidemiology and antimicrobial resistance • Diagnostics, prevention, and treatment

Bild